| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.07▼ | 2.06▲ | 2.06▲ | 2.14▼ | 2.22▼ |
| MA10 | 2.05▲ | 2.05▲ | 2.07▲ | 2.19▼ | 2.34▼ |
| MA20 | 2.10▼ | 2.12▼ | 2.14▼ | 2.25▼ | 2.36▼ |
| MA50 | 2.18▼ | 2.19▼ | 2.22▼ | 2.33▼ | 3.39▼ |
| MA100 | 2.24▼ | 2.26▼ | 2.33▼ | 2.44▼ | 4.28▼ |
| MA200 | 2.39▼ | 2.42▼ | 2.36▼ | 3.45▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | 0.000▼ | -0.003▼ | -0.014▼ | 0.046▲ |
| RSI | 43.913▼ | 43.125▼ | 42.624▼ | 40.344▼ | 39.762▼ |
| STOCH | 67.746 | 38.122 | 29.312 | 28.738 | 27.991 |
| WILL %R | -64.706 | -73.913 | -73.913 | -66.667 | -90.592▼ |
| CCI | 21.212 | -24.679 | -34.426 | -132.783▼ | -76.943 |
|
Tuesday, October 28, 2025 04:24 AM
The projected fair value for Abbott Laboratories is US$95.46 based on 2 Stage Free Cash Flow to Equity Current share price of US$127 suggests Abbott Laboratories is potentially 33% overvalued The ...
|
|
Abbott Laboratories (ABT) Rated Buy as Benchmark Highlights Diagnostics Growth and Global Resilience
Tuesday, October 21, 2025 03:33 AM
Abbott Laboratories (NYSE:ABT) ranks among the best medical device stocks to invest in. Benchmark began coverage of Abbott Laboratories (NYSE:ABT) on October 10 with a $145 price target and a Buy ...
|
|
Wednesday, October 15, 2025 04:56 AM
Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 6.9% year on year to $11.37 billion. Its non-GAAP profit of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/10/25 | 2.04 | 2.14 | 2.01 | 2.14 | 29,500 |
| 29/10/25 | 2.04 | 2.09 | 2.0101 | 2.07 | 14,779 |
| 28/10/25 | 2.17 | 2.171 | 2.0701 | 2.10 | 31,738 |
| 27/10/25 | 2.18 | 2.20 | 2.15 | 2.19 | 26,345 |
| 24/10/25 | 2.16 | 2.24 | 2.16 | 2.22 | 25,905 |
| 23/10/25 | 2.2297 | 2.2297 | 2.125 | 2.22 | 12,635 |
| 22/10/25 | 2.23 | 2.26 | 2.15 | 2.20 | 54,133 |
| 21/10/25 | 2.23 | 2.30 | 2.20 | 2.29 | 25,120 |
| 20/10/25 | 2.21 | 2.27 | 2.20 | 2.25 | 42,317 |
| 17/10/25 | 2.24 | 2.25 | 2.21 | 2.24 | 8,776 |
|
|
||||
|
|
||||
|
|